Aldeyra Therapeutics (ALDX)
1.65
-0.11 (6.25%)
Upcoming Events
Latest Headlines
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
June 2, 2026 7:01 AM - BizWire
Form SCHEDULE 13G/A Aldeyra Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
May 15, 2026 4:00 PM - SEC Filing
Form 10-Q Aldeyra Therapeutics, For: Mar 31
May 7, 2026 4:03 PM - SEC Filing
Form 8-K Aldeyra Therapeutics, For: May 01
May 1, 2026 11:52 AM - SEC Filing
Form ARS Aldeyra Therapeutics, For: Dec 31
April 27, 2026 4:18 PM - SEC Filing
Form DEFA14A Aldeyra Therapeutics,
April 27, 2026 4:16 PM - SEC Filing
Form DEF 14A Aldeyra Therapeutics, For: Jun 10
April 27, 2026 4:10 PM - SEC Filing
Form 8-K Aldeyra Therapeutics, For: Apr 20
April 20, 2026 5:00 PM - SEC Filing
Form 8-K Aldeyra Therapeutics, For: Apr 01
April 1, 2026 4:26 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Mar 27 Filed by: Brady Todd C
March 31, 2026 4:19 PM - SEC Filing
Form SCHEDULE 13G/A Aldeyra Therapeutics, Filed by: VANGUARD GROUP INC
March 26, 2026 3:26 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Mar 19 Filed by: DOUGLAS RICHARD
March 20, 2026 4:18 PM - SEC Filing
Form 4 Aldeyra Therapeutics, For: Mar 18 Filed by: Alfieri Michael
March 19, 2026 5:29 PM - SEC Filing
Aldeyra Therapeutics ALERT: Securities Fraud Investigation by Block & Leviton Could Allow $ALDX Shareholders to Recover Losses
March 18, 2026 10:05 AM - StreetInsider
H.C. Wainwright Downgrades Aldeyra Therapeutics (ALDX) to Neutral
March 18, 2026 6:33 AM - StreetInsider
Increasing unusual put option volume: ALDX STWD JBL EWT FIVE KPTI BKLN
March 18, 2026 5:57 AM - StreetInsider
BTIG on Aldeyra Therapeutics (ALDX): CRL 'hard to defend,' path to clarity within 90 days
March 17, 2026 4:08 PM - StreetInsider
$ALDX ALERT: Aldeyra Therapeutics, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
March 17, 2026 2:45 PM - Globe NewsWire
Increasing unusual put option volume: ALDX BW BKLN BXSL SMCX IQ MET FEZ MVST HTGC ASO SDOW
March 17, 2026 10:39 AM - StreetInsider
Form 8-K Aldeyra Therapeutics, For: Mar 17
March 17, 2026 8:40 AM - SEC Filing
Aldeyra receives FDA rejection for dry eye drug reproxalap
March 17, 2026 8:30 AM - StreetInsider
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
March 17, 2026 8:30 AM - BizWire
Increasing unusual put option volume: ALDX DKS BMBL BBBY LWLG BURL DHT SCO PATH
March 12, 2026 9:55 AM - StreetInsider
Full Article List
